The scientific class of CLL is rather heterogeneous, starting from a reasonably asymptomatic disease which will even regress spontaneously into a progressive condition that eventually results in the patient’s Demise, so there has generally been outstanding desire in figuring out the prognosis of unique patients. Although a lot of prognostic marke